Clinical Trial Update: Phase 2b Study of GAM501 in the Treatment of Diabetic Ulcers of the Lower Extremities [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2b study evaluating GAM501 for the treatment of diabetic foot ulcers of the lower extremities.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• GAM501

Snippet

Sponsor: Tissue Repair Company | Conditions: Diabetic Foot | Phase 2 | Status: COMPLETED